Live Breaking News & Updates on Travere Therapeutics Company Profile

Stay updated with breaking news from Travere therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $16.69

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective […] ....

Dynamic Technology Lab Private Ltd , Nisa Investment Advisors , Travere Therapeutics Company Profile , Canaccord Genuity Group , China Universal Asset Management Co , Entrypoint Capital , Wells Fargo Company , Travere Therapeutics Inc , Travere Therapeutics , Get Free Report , Genuity Group , Wells Fargo , Therapeutics Trading Down , Point Capital , Investment Advisors , Universal Asset Management , Get Free , Iga Nephropathy , Travere Therapeutics Daily ,

HC Wainwright Weighs in on Travere Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:TVTX)

HC Wainwright Weighs in on Travere Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:TVTX)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper Sandler , Proshare Advisors , Canaccord Genuity Group , Oak Ridge Investments , Russell Investments Group Ltd , Mirae Asset Global Investments Co , Travere Therapeutics Company Profile , Wells Fargo Company , Travere Therapeutics Inc , Capital Partners , Travere Therapeutics , Free Report , Travere Therapeutic , Genuity Group , Get Free Report , Share Advisors , Investments Group , Bridge Investments , Mirae Asset Global Investments , Asset Global Investments , Iga Nephropathy , Travere Therapeutics Daily ,

Travere Therapeutics (NASDAQ:TVTX) Shares Gap Up Following Analyst Upgrade

Travere Therapeutics (NASDAQ:TVTX) Shares Gap Up Following Analyst Upgrade
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , Piper Sandler , Cheyne Capital Management United Kingdom , Travere Therapeutics Inc , Emerald Advisers , Wells Fargo Company , Travere Therapeutics Company Profile , Emerald Mutual Fund Advisers , Canaccord Genuity Group , Travere Therapeutics , Get Free Report , Genuity Group , Kantonalbank Zurich Cantonalbank , Mutual Fund Advisers Trust , Capital Management United Kingdom , Teacher Retirement System , Retirement System , Iga Nephropathy , Travere Therapeutics Daily ,

Analysts Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $17.85

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has received an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective […] ....

Los Angeles , United States , Ericm Dube , Piper Sandler , Travere Therapeutics Company Profile , Los Angeles Capital Management , Securities Exchange Commission , China Universal Asset Management Co , Travere Therapeutics Inc , Hennion Walsh Asset Management Inc , Healthcare Of Ontario Pension Plan Trust Fund , Rice Hall James Associates , Wells Fargo Company , Travere Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Universal Asset Management , Hall James , Walsh Asset Management , Angeles Capital Management , Ontario Pension Plan Trust Fund , Get Free , Iga Nephropathy , Travere Therapeutics Daily , Nasdaq Tvtx ,

Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $17.85

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average […] ....

Peter Heerma , Piper Sandler , Christopherr Cline , Zurcher Kantonalbank Zurich Cantonalbank , Wells Fargo Company , Dynamic Technology Lab Private Ltd , Nisa Investment Advisors , Securities Exchange Commission , Travere Therapeutics Company Profile , China Universal Asset Management Co , Travere Therapeutics Inc , Travere Therapeutics , Get Free Report , Exchange Commission , Investment Advisors , Universal Asset Management , Technology Lab Private Ltd , Kantonalbank Zurich Cantonalbank , Get Free , Iga Nephropathy , Travere Therapeutics Daily ,